APVOVSMREO• 3 Months (Normalized)
APVO vs MREO (Aptevo Therapeutics Inc. vs Mereo BioPharma Group plc)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
APVO Performance $1.72
-63.17%
Aptevo Therapeutics Inc.
Normalized Baseline0.00%
MREO Performance $0.27
-13.92%
Mereo BioPharma Group plc
Normalized Baseline0.00%
Alpha Spread Margin MREO LEADS
-49.25%
MREO outperforming by 49.25%
APVOMREO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
APVO MREO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | APVO Price | APVO Gain (%) | MREO Price | MREO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.72 | -63.17% | $0.27 | -13.92% | -49.25% |
| Sep 15, 2026 | $1.71 | -63.38% | $0.29 | -7.77% | -55.61% |
| Sep 14, 2026 | $1.80 | -61.46% | $0.28 | -9.39% | -52.07% |
| Sep 11, 2026 | $1.82 | -61.03% | $0.28 | -9.39% | -51.64% |
| Sep 10, 2026 | $1.83 | -60.81% | $0.25 | -20.71% | -40.10% |
| Sep 09, 2026 | $1.85 | -60.49% | $0.24 | -21.36% | -39.13% |
| Sep 08, 2026 | $1.88 | -59.74% | $0.26 | -17.48% | -42.26% |
| Sep 04, 2026 | $1.74 | -62.74% | $0.25 | -19.09% | -43.65% |
| Sep 03, 2026 | $1.71 | -63.38% | $0.27 | -11.97% | -51.41% |
| Sep 02, 2026 | $2.60 | -44.33% | $0.27 | -13.59% | -30.74% |
| Sep 01, 2026 | $2.34 | -49.89% | $0.28 | -10.36% | -39.53% |
| Aug 31, 2026 | $2.44 | -47.75% | $0.27 | -13.59% | -34.16% |
| Aug 28, 2026 | $2.37 | -49.36% | $0.25 | -18.12% | -31.24% |
| Aug 27, 2026 | $2.42 | -48.18% | $0.27 | -11.97% | -36.21% |
| Aug 26, 2026 | $2.41 | -48.39% | $0.28 | -10.03% | -38.36% |
Page 1 of 5